Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany
- Post-therapy whole-body scan with abnormal radioactive iodine localized to the head of two women. Lee, Stephanie L. // Endocrine Today;Jan2011, Vol. 9 Issue 1, p19
This article discusses the case of a young woman who received radioactive iodine remnant ablation for multifocal micropapillary thyroid carcinoma.
- Identification of Intermediate- to High-Risk Papillary Thyroid Carcinoma Patients Who May Be Safely Managed without the Performance of Delayed Stimulated Thyroglobulin Measurements following Total Thyroidectomy and Radioactive Iodine Therapy. Kim, Kyung-Hee; Kim, Min-Hee; Lim, Ye-Jee; Lee, Ihn Suk; Bae, Ja-Seong; Lim, Dong-Jun; Baek, Ki Hyun; Lee, Jong Min; Kang, Moo-Il; Cha, Bong-Yun // International Journal of Endocrinology;1/12/2015, Vol. 2015, p1
Background. The measurement of stimulated thyroglobulin (sTg) after total thyroidectomy and remnant radioactive iodine (RAI) ablation is the gold standard for monitoring disease status in patients with papillary thyroid carcinomas (PTCs). The aim of this study was to determine whether sTg...
- Effect of a Low Iodine Diet vs. Restricted Iodine Diet on Postsurgical Preparation for Radioiodine Ablation Therapy in Thyroid Carcinoma Patients. Chi Young Lim; Jung-Yeon Kim; Mi-Jin Yoon; Hang Seok Chang; Cheong Soo Park; Woong Youn Chung // Yonsei Medical Journal;Jul2015, Vol. 56 Issue 4, p1021
Purpose: The radioiodine ablation therapy is required for patients who underwent a total thyroidectomy. Through a comparative review of a low iodine diet (LID) and a restricted iodine diet (RID), the study aims to suggest guidelines that are suitable for the conditions of Korea. Materials and...
- Correction: Changes in the Pulmonary Function Test after Radioactive Iodine Treatment in Patients with Pulmonary Metastases of Differentiated Thyroid Cancer. null, null // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1
No abstract available.
- Radioactive Iodine Administration Is Associated with Persistent Related Symptoms in Patients with Differentiated Thyroid Cancer. Florenzano, Pablo; Guarda, Francisco J.; Jaimovich, Rodrigo; Droppelmann, Nicolás; González, Hernán; Domínguez, José M. // International Journal of Endocrinology;10/27/2016, p1
Context. Radioiodine (RAI) administration has adverse effects in patients treated for thyroid cancer (DTC), but there is scarce information regarding their intensity and duration. Objective. To evaluate frequency and intensity of early and late RAI-related symptoms in patients with DTC. Design....
- Difficulties in deciding whether to ablate patients with putatively 'low-intermediate-risk' differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study. Frangos, Savvas; Iakovou, Ioannis; Marlowe, Robert; Eftychiou, Nicolaos; Patsali, Loukia; Vanezi, Anna; Savva, Androulla; Mpalaris, Vassilis; Giannoula, Evanthia // European Journal of Nuclear Medicine & Molecular Imaging;Dec2015, Vol. 42 Issue 13, p2045
Purpose: We determined the reasons for radioiodine thyroid remnant ablation, and the procedure's necessity based on postsurgical remnant size, in patients with putatively 'low-intermediate-risk' differentiated thyroid carcinoma (DTC). We identified key clinicopathological, treatment and remnant...
- Assessment of radioiodine therapy efficacy for treatment of differentiated thyroid cancer patients with pulmonary metastasis undetected by chest computed tomography. BIN LONG; MENGDI YANG; ZHIWEN YANG; HEQING YI; LINFA LI // Oncology Letters;Feb2016, Vol. 11 Issue 2, p965
Radioiodine therapy (RAI) has proven effective for the treatment of patients exhibiting differentiated thyroid cancer (DTC) with pulmonary metastases. However, the early detection of metastasis remains challenging, and various studies have reported variations in radioiodine treatment efficacy....
- Effectiveness of L-thyroxine treatment on TSH suppression during pregnancy in patients with a history of thyroid carcinoma after total thyroidectomy and radioiodine ablation. Krhin, Blaz; Besic, Nikola // Radiology & Oncology;2012, Vol. 46 Issue 2, p160
Introduction. There are scarce data about the optimal increase of L-thyroxine dose during pregnancy in patients with a history of thyroid carcinoma. The first aim of the study was to find out if routine therapeutic measures enable adequate TSH suppression in pregnancy. The other aim was to find...
- Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Sciuto, R.; Romano, L.; Rea, S.; Marandino, F.; Sperduti, I.; Maini, C. L. // Annals of Oncology;Oct2009, Vol. 20 Issue 10, p1728
Background: The study evaluates clinical presentation and outcome of differentiated thyroid cancer (DTC) on a large series of patients homogeneously managed.